Trihexyphenidyl potentiation of L-DOPA: Reduced effectiveness three years later in MPTP-induced chronic hemiparkinsonian monkeys

Experimental Neurology

Volumn 152, Issue 2, 1998, Pages 238-242

  Domino, Edward F ^a   Ni, Lisong ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Hemiparkinsonism; L DOPA methyl ester; Monkeys; MPTP; Trihexyphenidyl

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; LEVODOPA; TRIHEXYPHENIDYL;

ADOLESCENT; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; MACACA; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL;

EID: 0032143829     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1998.6859     Document Type: Article

References (12)

1. Bankiewicz K. S., Oldfield E. H., Chiueh C. C., Doppman J. L., Jacobowitz D. M., Kopin I. J. Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Life. Sci. 39:1986;7-16.
2. 2. Movement Dis. 9:1994;147-154.
3. 121. J. Pharmacol. Exp. Ther. 164:1993a;221-225.
4. 12. J. Pharmacol. Exp. Ther. 165:1993b;1387-1391.
5. Domino E. F., Ni L., Zhang H., Kohno Y., Sasa M. Talipexole or pramipexole combinations with chloro-APB (SKF 82958) in MPTP induced hemiparkinsonian monkeys. Eur. J. Pharmacol. 325:1997;137-144.
6. Domino, E. F. L. Ni, H. Zhang, Y. Kohno, M. Sasa, 1998, Effects of talipexole on contraversive rotation and functional impairments in MPTP induced hemiparkinsonian monkeys, Jpn. J. Pharmacol. in press.
7. Emborg-Knott, M. E. E. F. Domino, 1998, MPTP-induced hemiparkinsonism in nonhuman primates 6-8 years after a single intracarotid dose, Exp. Neurol./Neurodegeneration, in press.
8. 1. Brit. J. Pharmacol. 89:1986;83-90.
9. Standaert D. G., Young A. B. Treatment of central nervous system degenerative disorders. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 1996;McGraw-Hill, New York. p. 503-519.
10. Tien X.-Y., Wallace L. J. Trihexyphenidyl-Further evidence for muscarinic receptor subclassification. Biochem. Pharmacol. 34:1985;588-590.
11. Tsui J. K. C. Chapter 34. Treatment of Parkinson's Disease. Calne D. B. Neurodegenerative Diseases. 1994;573-582 Saunders, Philadelphia.
12. Ungerstedt U. Chapter 60. Brain dopamine neurons and behavior. Schmitt F. O., Worden F. G. The Neurosciences Third Study Program. 1974;695-703 MIT Press, Cambridge.